Page last updated: 2024-10-26

valproic acid and Blepharospasm-Oromandibular Dyskinesia

valproic acid has been researched along with Blepharospasm-Oromandibular Dyskinesia in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"Methylphenidate is a short-acting stimulant."1.39Methylphenidate-induced acute orofacial and extremity dyskinesia. ( Donmez, A; Isik, B; Orun, E; Sonmez, FM; Tas, T; Yilmaz, AE, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yilmaz, AE1
Donmez, A1
Orun, E1
Tas, T1
Isik, B1
Sonmez, FM1
Snoek, JW1
van Weerden, TW1
Teelken, AW1
van den Burg, W1
Lakke, JP1

Trials

1 trial available for valproic acid and Blepharospasm-Oromandibular Dyskinesia

ArticleYear
Meige syndrome: double-blind crossover study of sodium valproate.
    Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:11

    Topics: Basal Ganglia Diseases; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Male; Meige Sy

1987

Other Studies

1 other study available for valproic acid and Blepharospasm-Oromandibular Dyskinesia

ArticleYear
Methylphenidate-induced acute orofacial and extremity dyskinesia.
    Journal of child neurology, 2013, Volume: 28, Issue:6

    Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; C

2013